Shanghai RAAS Blood Products Co., Ltd.
002252
Kedudukan dalam Saham
#3642
Shanghai RAAS Blood Products Co., Ltd. engages in the research, development,... Shanghai RAAS Blood Products Co., Ltd. engages in the research, development, production, and sale of blood products. It provides human albumin, intravenous injection of human immunoglobulin, coagulation factor products, vaccines, diagnostic reagents, and testing services. The company was founded by Kieu Hoang on October 29, 1988 and is headquartered in Shanghai, China.
Harga Saham
$0.70717976
Modal Pasaran
$4.66B
Perubahan (1 hari)
-0.20%
Perubahan (1 tahun)
-24.51%
Negara
CN
Perdagangan Shanghai RAAS Blood Products Co., Ltd. (002252)
Kategori
Healthcare
Sejarah hasil dividen untuk Shanghai RAAS Blood Products Co., Ltd. (002252)
Hasil dividen (TTM) bagi Shanghai RAAS Blood Products Co., Ltd. (simbol saham: 002252) pada 2023-12-31 adalah: 0.40%
Purata hasil dividen 5 tahun terakhir: 0.45%
Purata hasil dividen 5 tahun terakhir: 0.45%
Sejarah hasil dividen untuk Shanghai RAAS Blood Products Co., Ltd. (002252) dari 2005 hingga 2026
Hasil dividen pada akhir setiap tahun (TTM)
| Tahun | Hasil Dividen | Ubah |
|---|---|---|
| 2026 (TTM) | 0.97% | 5.43% |
| 2024 | 0.92% | 130.00% |
| 2023 | 0.40% | -9.09% |
| 2022 | 0.44% | 18.92% |
| 2021 | 0.37% | 164.29% |
| 2020 | 0.14% | 0.00% |
| 2019 | 0.00% | -100.00% |
| 2018 | 0.43% | 95.45% |
| 2017 | 0.22% | 46.67% |
| 2016 | 0.15% | 7.14% |
| 2015 | 0.14% | -6.67% |
| 2014 | 0.15% | 200.00% |
| 2013 | 0.05% | -95.10% |
| 2012 | 1.02% | 21.43% |
| 2011 | 0.84% | 33.33% |
| 2010 | 0.63% | -42.20% |
| 2009 | 1.09% | 45.33% |
| 2008 | 0.75% | -59.89% |
| 2007 | 1.87% | -9.66% |
| 2006 | 2.07% | 567.74% |
| 2005 | 0.31% | 0.00% |
Hasil dividen (TTM) untuk syarikat serupa atau pesaing
| Syarikat | Hasil Dividen | Negara |
|---|---|---|
| 0.00% |
US
|
|
| 0.00% |
US
|
|
| 2.17% |
AU
|
|
| 0.00% |
CH
|
|
| 0.00% |
NL
|
